Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Arrived
EquityMultiple
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
RLYB
Stock Latest News
Ratings
Buy Rating for Rallybio: Progress in Key Therapeutics and Promising Catalysts
20d ago
RLYB
Premium
The Fly
Rallybio announces initiation of dosing in RLYB212 Phase 2 trial
21d ago
RLYB
Premium
The Fly
Rallybio price target lowered to $7 from $8 at JMP Securities
3M ago
RLYB
Premium
The Fly
Rallybio to begin RLYB116 confirmatory clinical PK/PD study in Q2
3M ago
RLYB
Premium
The Fly
Rallybio publishes RLYB212 data
3M ago
RLYB
Premium
The Fly
Rallybio announces initiation of Phase 2 clinical trial of RLYB212
3M ago
RLYB
Premium
The Fly
Rallybio price target lowered to $5 from $6 at H.C. Wainwright
4M ago
RLYB
Premium
The Fly
Rallybio reports Q3 EPS (26c), consensus (35c)
4M ago
RLYB
Premium
The Fly
Rallybio’s trial applications of RLYB212 in pregnant women with FNAIT approved
4M ago
RLYB
Premium
The Fly
Rallybio participates in a conference call with JPMorgan
5M ago
RLYB
Premium
Company Announcements
Dr. Kush Parmar Steps Down from Rallybio’s Board and Committee
6M ago
8K
RLYB
Premium
The Fly
Rallybio announces data from Phase 1 PoC sudy of RLYB212
6M ago
RLYB
Premium
The Fly
Rallybio price target lowered to $6 from $9 at H.C. Wainwright
7M ago
RLYB
Premium
The Fly
Rallybio reports Q2 EPS (37c), consensus (37c)
7M ago
RLYB
Premium
Company Announcements
Rallybio Executive Chairman Announces Plans to Step Down
7M ago
8K
RLYB
Premium
The Fly
Rallybio reports results from epidemiological analysis evaluating FNAIT risk
9M ago
RLYB
Premium
The Fly
Rallybio downgraded to Neutral from Overweight at JPMorgan
10M ago
RLYB
Premium
The Fly
Rallybio files to sell 3.64M shares of common stock for holders
10M ago
RLYB
Premium
The Fly
Rallybio reports Q1 EPS (47c), consensus (47c)
10M ago
RLYB
Premium
The Fly
Rallybio price target lowered to $11 from $13 at Wedbush
11M ago
JNJ
RLYB
Premium
Company Announcements
Rallybio Strengthens Ties with J&J in FNAIT Treatment Push
11M ago
8K
RLYB
Premium
The Fly
Rallybio to partner with J&J on soultions to reduce risk of FNAIT
11M ago
JNJ
RLYB
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
